Search Results 1381-1390 of 16291 for Chronic Lymphocytic Leukemia
Participation eligibility · Women with a pathologic diagnosis of OC. · Able to provide informed consent. · Patients receiving treatment at Mayo Clinic Rochester.
... Leukemia (AML) who are eligible for standard induction and consolidation chemotherapy. Participation eligibility. Participant eligibility includes age ...
Class II), poorly controlled diabetes, severe chronic pulmonary disease, coronary angioplasty or myocardial infarction within the last 6 months or ...
The main purpose of this extended study is to evaluate the long term effectiveness of the study drug LY2951742 in patients who have chronic cluster headaches.
The purpose of this study is to provide additional treatment with NEOD001 and evaluate long term safety and tolerability for patients wih light chain ...
About this study. The purpose of this research study is to understand the views and experiences of African American women with a diagnosis or who support a ...
... long term survival. Our goal is to identify ... leukemia/lymphoma. A Study to Evaluate the ... leukaemia (AML)/high-risk myelodysplastic syndrome ...
A long-term strategy for management of multiple myeloma should include a risk-stratified approach as well as selecting the ideal combinations and sequencing ...
... diagnosis. "Triple negative is a form of breast cancer in which there is no expression of estrogen receptor, no expression of progesterone receptor and no ...
... chronic liver disease. 5) Child-Pugh score A–B8. 6) Subject must be able to understand and provide informed consent. Controls. 1) Males and females ages 18 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.